Carrum Health, an innovative surgery benefit offered to self-insured employers, has expanded into Nevada through a partnership with Crovetti Orthopaedics and Sports Medicine. Through the partnership, Carrum Health members will be able to receive specialized joint care, including hip, knee and shoulder surgeries and replacements, as well as sports medicine services through Crovetti Orthopaedics.
The Crovetti Orthopedics team provides ongoing patient education, from pre-op to post-op, including onsite aftercare and guidance on transitioning to home for continued recovery. In the Recovery Suites, patients have access to 24-hour personalized care by trained surgical nurses, as well as accelerated rehabilitation protocols, healthy catered meals, and visitor accommodations to make recovery comfortable and ensure optimal outcomes.
“Carrum Health wants to make it easy for our members to get the best care, close to home,” said Christoph Dankert, Senior Vice President for Provider Partnerships at Carrum Health. “Our entry into Nevada and the partnership with Crovetti Orthopaedics underscores this commitment to have a regional COE for musculoskeletal care within a short drive, regardless of where they live.”
Symptom management is an important aspect of cancer care. A recent study has shown that engaged lung cancer patients can lead to a 16%-53% improvement in survival rates.
Outcomes4Me Inc., developer of a free mobile app and platform to navigate cancer treatment and care, found inconsistencies on what symptoms patients report to their doctors through their recollection versus what they report in real time with Outcomes4Me. Many of these inconsistencies are driven by not wanting to bother the doctor and under reporting of symptoms especially those related to sexual health.
In light of these inconsistencies in symptom tracking, the company has launched a new app update to ensure that patients can track and monitor their symptoms even faster and more simply. Outcomes4Me redesigned symptom tracking, upon the recommendation of the FDA, using PRO-CTCAE, a patient-reported outcome measurement system developed by the National Cancer Institute to capture symptomatic adverse events in patients on cancer clinical trials. Now patients can track symptoms and learn how to proactively manage them in real time, visualize symptom trends with new color coded bar graphs, and share a free, easy-to-read symptom report with physicians. This update is available on Android and iOS devices.
Seven Bridges, this week announced the appointment of Viresh Patel, Ph.D., as its new senior vice president of marketing. Dr. Patel is a proven life sciences industry executive and renowned genomics marketer. He joins Seven Bridges as the company looks to scale its marketing and commercial operations in order to accelerate scientific discovery and deepen its impact in precision medicine.
“Viresh brings a wealth of experience leading dynamic marketing teams and launching innovative life sciences tools and diagnostic products with a high degree of commercial success,” said Bill Moss, chief executive officer of Seven Bridges. “Coming off a stellar 2020 where we extended our commercial and academic partnerships, launched two new products (ARIA and GRAF), and won numerous industry accolades, Viresh will help us accelerate our growth in 2021 and beyond by simultaneously bringing a deep understanding of the life sciences industry and a fresh perspective on what’s needed to advance the field of genomics.”
To read more on this announcement, view the full press release here.
A company that provides behavioral health services for primary care, Concert Health, raised $14 million in a Series A round led by Vertical Venture Partners, with participation from Town Hall Ventures and Silicon Valley Bank. Concert plans to use the funds to grow its team, ramp up training programs and built out its technology platform. To read more, click here.
Picture: akindo, Getty Images
